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Vitamin D status in critically ill patients: the
evidence is now bioavailable!
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1,2* and Sadeq A Quraishi
1
See related research by Amrein et al., http://ccforum.com/content/18/2/R47
We read with great interest the recent article by Amrein
and colleagues demonstrating an association between
25-hydroxyvitamin D (25(OH)D) levels and adjusted
hospital mortality (hazard ratio 2.05; 95% confidence
interval 1.31 to 3.22) [1]. Interestingly, in this large co-
hort of ICU patients, no individual with 25(OH)D levels
≥30 ng/ml died from sepsis. However, the investigators
did not appreciate an association of 25(OH)D levels with
hospital length of stay, ICU mortality, blood culture posi-
tivity, or inflammatory markers. We hypothesize that these
negative findings may be explained by the fact that only
total serum 25(OH)D levels were available for the analysis.
Circulating 25(OH)D levels are considered the best in-
dicator of vitamin D status in the general population [2].
However, 25(OH)D is predominantly bound to vitamin
D binding protein in a very stable complex; indeed, only
free and albumin-bound 25(OH)D may be considered
available for biological functions [3]. Formulas used to
calculate the bioavailable fraction, however, were not de-
rived from critically ill patients and may be inadequate
in the ICU setting. In addition, expression of human
cathelicidin, a potent vitamin D-dependent antimicrobial
peptide, is suppressed in the setting of low 25(OH)D
levels [4]. Moreover, how bioavailable 25(OH)D and
cathelicidin expression change over the course of critical
illness remains unclear [5].
Hence, we strongly urge future studies related to vita-
min D status in critical illness to consider incorporating
direct measurements of bioavailable 25(OH)D and
cathelicidin expression to further our understanding of
the potential underlying biological mechanisms by which
vitamin D optimization may improve ICU outcomes.
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Authors' response
Karin Amrein, Paul Zajic, Steven Amrein and Harald Dobnig
De Pascale and Quraishi raise a very important topic:
how can we best assess an individual’s vitamin D status?
The answer is that no one knows; not in healthy per-
sons, and even less so in critical illness.
Certainly the intricate interplay of calcium and phos-
phate homeostasis, parathyroid hormone, fibroblast
growth factor-23, and vitamin D metabolites is profoundly
disturbed in critical illness, and particularly in sepsis. For a
long time, total serum 25(OH)D was considered to best
reflect an individual’s vitamin D status [6]. Recently, this
choice of marker has been questioned because polymor-
phisms in the vitamin D binding protein gene seem to
have important consequences on bioavailable 25(OH)D
concentrations [7]. Moreover, vitamin D status at a tissue
level is not measurable and the importance of circulating
1,25-dihydroxyvitamin D is unclear, although an associ-
ation with mortality is known [8]. All of these consider-
ations are true in critical illness, but there are even more
potential confounders such as inflammation and acute
fluid loading that may affect vitamin D concentrations.
In our retrospective cohort, we were partially able to
adjust for these factors [1]. Unfortunately, vitamin D
binding protein was not routinely measured, and thus
we are unable to reanalyze our data to answer the very
interesting question of whether an association of bio-
available 25(OH)D concentrations with clinically import-
ant outcomes is present. We agree that it may be
important not only to correlate clinical outcomes with
total 25(OH)D status, but also to consider respective
changes in the bioavailable fraction. Besides prospective
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http://ccforum.com/content/18/4/449studies on how to assess vitamin D deficiency in this
special setting, it will be crucial to perform large, well-
planned multicenter randomized controlled trials to
evaluate the effects of vitamin D on clinical outcomes,
taking into account the important basic rules regarding
the design for clinical studies on nutrient effects [9].
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